Email ID
Sign me in automatically next time
Narrowing price gap may not make Roche's Lucentis more attractive than Eylea

Roche has cut the price of of its ophthalmology drug Lucentis so that its cost compared more closely with the newly approved and marketed competitor, Eylea from Regeneron. But analysts...
02 March 2012
Nancy Faigen

Please Login to read the full article.
04 April 2016
Stockholm, Sweden
06 April 2016
Hamburg, Germany
JOB OF THE WEEK Promote your job vacancy
© 2016 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36